跳至主要内容
临床试验/NCT05352308
NCT05352308Unknown不适用

The Evaluation of a Narrative Communication Intervention to Increase Human Papillomavirus Vaccination Intentions and Uptake in a Hispanic-Majority College Population

Sara Fleszar0 个研究点目标入组 300 人开始时间: 2022年4月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
主要终点
Change from baseline to immediately post-intervention in intentions

研究概览

简要总结

The current study aims to evaluate a newly developed CSM narrative intervention in increasing HPV vaccination intentions and uptake in adults aged 18 to 26 years. The efficacy of the newly designed CSM-guided narrative video will be compared against a time and attention video and the standard of care print educational materials in increasing the intentions and uptake of the HPV vaccine in an adult Hispanic-majority college population. It is expected that participants receiving the CSM-guided narrative video will have greater HPV vaccine intentions compared with participants in the time and attention video and standard of care print education material groups. It is also hypothesized that participants receiving the CSM-guided narrative video will have greater HPV vaccine uptake at one month post-intervention compared with participants in the time and attention video and standard of care print education material groups.

详细描述

The current study aims to evaluate a newly developed CSM narrative intervention in increasing HPV vaccination intentions and uptake in adults aged 18 to 26 years. The efficacy of the newly designed CSM-guided narrative video will be compared against a time and attention video and the standard of care print educational materials in increasing the intentions and uptake of the HPV vaccine in an adult Hispanic-majority college population.

Main Hypotheses:

H1. Participants receiving the CSM-guided narrative video will have greater HPV vaccine intentions compared with participants in the time and attention video and standard of care print education material groups.

H2. Participants receiving the CSM-guided narrative video will have greater HPV vaccine uptake at one month post-intervention compared with participants in the time and attention video and standard of care print education material groups.

Secondary Hypotheses:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 26 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Undergraduate students enrolled in the university's SONA system
  • Aged 18-26 years
  • Have not received any doses of the HPV vaccine
  • Have working audio (e.g., headphones/speakers)

排除标准

  • Students who are not undergraduates
  • Undergraduates not participating in the university's SONA system
  • Aged <18 or >26 years
  • Have received any dose/shot (1st, 2nd, or 3rd doses/shots) of the HPV vaccine
  • Do not have working audio (e.g., headphones/speakers)

结局指标

主要结局

Change from baseline to immediately post-intervention in intentions

时间窗: Baseline to 2 days post-baseline

Intentions will be assessed with a previous measure to assess behavioral intentions (α = .92 in a sample of young adults; Moyer-Guse, Chung, \& Jain, 2011) which has been adapted for use to assess intentions to engage in several HPV-related behaviors (Landrau, 2020). The assessment asks participants, on a scale of 1 = definitely will not to 7 = definitely will, "What is the likelihood that you will": (1) "Get the HPV vaccine within the next 30 days" and (2) "Get the HPV vaccine within the next 12 months." Several other HPV-related behaviors are assessed by asking participants, "What is the likelihood that you will engage in the following behaviors over the next 6 months on a scale of 0 = definitely will not to 6 = definitely will." Sample statements include (1) "Discuss the HPV vaccine with a healthcare provider" and (2) "Search for more information about the HPV vaccine." Higher scores indicate higher intentions to engage in HPV-related behaviors.

Change from immediately post-intervention to one-month post-intervention in intentions

时间窗: 2 days post-baseline to one month post-baseline

Intentions will be assessed with a previous measure to assess behavioral intentions (α = .92 in a sample of young adults; Moyer-Guse, Chung, \& Jain, 2011) which has been adapted for use to assess intentions to engage in several HPV-related behaviors (Landrau, 2020). The assessment asks participants, on a scale of 1 = definitely will not to 7 = definitely will, "What is the likelihood that you will": (1) "Get the HPV vaccine within the next 30 days" and (2) "Get the HPV vaccine within the next 12 months." Several other HPV-related behaviors are assessed by asking participants, "What is the likelihood that you will engage in the following behaviors over the next 6 months on a scale of 0 = definitely will not to 6 = definitely will." Sample statements include (1) "Discuss the HPV vaccine with a healthcare provider" and (2) "Search for more information about the HPV vaccine." Higher scores indicate higher intentions to engage in HPV-related behaviors.

次要结局

  • Change from baseline to immediately post-intervention in Effectiveness, Harms, Barriers, & Uncertainty of HPV Vaccine(baseline to 2 days post-baseline)
  • Change from immediately post-intervention to one-month post-intervention in Illness Risk Representations(2 days post-baseline to one month post-baseline)
  • Change from baseline to immediately post-intervention in Knowledge of HPV and HPV Vaccine(baseline to 2 days post-baseline)
  • Change from baseline to immediately post-intervention in Risk-Action Coherence(baseline to 2 days post-baseline)
  • Change from immediately post-intervention to one-month post-intervention in Risk-Action Coherence(2 days post-baseline to one month post-baseline)
  • Religious Commitment(baseline)
  • HPV Vaccine Uptake(one month post-baseline)
  • Change from baseline to immediately post-intervention in Illness Risk Representations(baseline to 2 days post-baseline)
  • Narrative Engagement(2 days post-baseline)
  • Realism(2 days post-baseline)
  • Change from baseline to immediately post-intervention in Perceived Severity & Susceptibility of the HPV Virus(baseline to 2 days post-baseline)

研究者

发起方
Sara Fleszar
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sara Fleszar

Principal Investigator

University of California, Merced

相似试验